LNSR - רווח נקי למניה (EPS TTM) LENSAR, Inc

Price action for LENSAR, Inc. (LNSR) depends on physicians' willingness to adopt lasers, the volume of insurance reimbursements, and clinic investments. LENSAR, Inc. (LNSR) revenues are based on the sale of license codes and proprietary cataract treatment systems, which create a stable cash flow through consumables. The rolling annual earnings per share visualizes fundamental profitability, and -0.40 reflects the most recent value of the metric.

This indicator is calculated by dividing the total annual net income by the total number of outstanding shares, reflecting the actual profit share attributable to a single security. By analyzing the 12-month rolling earnings per share history, an investor assesses the ability of LENSAR, Inc. (LNSR) to generate income amid aggressive dumping by medtech behemoths in the laser ophthalmology segment.